Mequitazine

Drug Profile

Mequitazine

Alternative Names: Butix; Histacoid; LM 209; Metaplexan; Mircol; Primalan; Quitadrill; Release; Sattol; Vigigan

Latest Information Update: 11 Jun 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Pierre Fabre; sanofi-aventis
  • Developer Asahi Kasei; G.L. Pharma; Inava; Italfarmaco
  • Class Antiallergics; Phenothiazines; Sedating antihistamines; Small molecules
  • Mechanism of Action Histamine H1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Allergic conjunctivitis; Allergic rhinitis; Pruritus; Rhinitis; Urticaria

Most Recent Events

  • 26 Aug 2004 Aventis has merged with Sanofi-Synthelabo to form Sanofi-Aventis
  • 16 May 2001 Pierre Fabre has merged with bioMérieux Alliance
  • 15 Jan 2001 Asahi Chemical is now called Asahi Kasei
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top